Finerenone
Treatment for Chronic Kidney Disease Due To Hypertension
Typical Dosage: 10-20mg daily
Effectiveness
88%
Safety Score
65%
Clinical Trials
20
Participants
13K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
10-20mg daily
Time to Effect
6-12 months for significant renoprotection
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
29(Treat 29 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10(Treat 10 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$7,000
Monitoring:$1,200
Side Effect Mgmt:$250
Total Annual:$8,450
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$80,000/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$24,143
Comparison vs Standard care (ACEi/ARB +/- SGLT2i)
Cost Difference
+$8,450/year
More expensive
QALY Difference
+0.60 QALYs
Better outcomes
Dominance
No dominance
Finerenone Outcomes
for Chronic Kidney Disease Due To Hypertension
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+35%
Common Side Effects
Hyperkalemia
+12%
Hypotension
+3%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov